These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 25119968)
21. Analysis of ataxia-telangiectasia mutated (ATM)- and Nijmegen breakage syndrome (NBS)-regulated gene expression patterns. Jang ER; Lee JH; Lim DS; Lee JS J Cancer Res Clin Oncol; 2004 Apr; 130(4):225-34. PubMed ID: 14745549 [TBL] [Abstract][Full Text] [Related]
22. Telomere attrition and dysfunction: a potential trigger of the progeroid phenotype in nijmegen breakage syndrome. Habib R; Kim R; Neitzel H; Demuth I; Chrzanowska K; Seemanova E; Faber R; Digweed M; Voss R; Jäger K; Sperling K; Walter M Aging (Albany NY); 2020 Jun; 12(12):12342-12375. PubMed ID: 32564008 [TBL] [Abstract][Full Text] [Related]
23. Chromosomal Instability and Molecular Defects in Induced Pluripotent Stem Cells from Nijmegen Breakage Syndrome Patients. Halevy T; Akov S; Bohndorf M; Mlody B; Adjaye J; Benvenisty N; Goldberg M Cell Rep; 2016 Aug; 16(9):2499-511. PubMed ID: 27545893 [TBL] [Abstract][Full Text] [Related]
24. Retroviral expression of the NBS1 gene in cultured Nijmegen breakage syndrome cells restores normal radiation sensitivity and nuclear focus formation. Cerosaletti KM; Desai-Mehta A; Yeo TC; Kraakman-Van Der Zwet M; Zdzienicka MZ; Concannon P Mutagenesis; 2000 May; 15(3):281-6. PubMed ID: 10792024 [TBL] [Abstract][Full Text] [Related]
25. Impact of heterozygous c.657-661del, p.I171V and p.R215W mutations in NBN on nibrin functions. Dzikiewicz-Krawczyk A; Mosor M; Januszkiewicz D; Nowak J Mutagenesis; 2012 May; 27(3):337-43. PubMed ID: 22131123 [TBL] [Abstract][Full Text] [Related]
26. The defect in humoral immunity in patients with Nijmegen breakage syndrome is explained by defects in peripheral B lymphocyte maturation. Piątosa B; van der Burg M; Siewiera K; Pac M; van Dongen JJ; Langerak AW; Chrzanowska KH; Bernatowska E Cytometry A; 2012 Oct; 81(10):835-42. PubMed ID: 22851427 [TBL] [Abstract][Full Text] [Related]
27. Nijmegen breakage syndrome (NBS) with neurological abnormalities and without chromosomal instability. Seemanová E; Sperling K; Neitzel H; Varon R; Hadac J; Butova O; Schröck E; Seeman P; Digweed M J Med Genet; 2006 Mar; 43(3):218-24. PubMed ID: 16033915 [TBL] [Abstract][Full Text] [Related]
28. Telomerase upregulation is a postcrisis event during senescence bypass and immortalization of two Nijmegen breakage syndrome T cell cultures. Degerman S; Siwicki JK; Osterman P; Lafferty-Whyte K; Keith WN; Roos G Aging Cell; 2010 Apr; 9(2):220-35. PubMed ID: 20089118 [TBL] [Abstract][Full Text] [Related]
29. Molecular basis of ataxia telangiectasia and related diseases. Ball LG; Xiao W Acta Pharmacol Sin; 2005 Aug; 26(8):897-907. PubMed ID: 16038621 [TBL] [Abstract][Full Text] [Related]
31. Growth of persistent foci of DNA damage checkpoint factors is essential for amplification of G1 checkpoint signaling. Yamauchi M; Oka Y; Yamamoto M; Niimura K; Uchida M; Kodama S; Watanabe M; Sekine I; Yamashita S; Suzuki K DNA Repair (Amst); 2008 Mar; 7(3):405-17. PubMed ID: 18248856 [TBL] [Abstract][Full Text] [Related]
32. Directed Alternative Splicing in Nijmegen Breakage Syndrome: Proof of Principle Concerning Its Therapeutical Application. Salewsky B; Hildebrand G; Rothe S; Parplys AC; Radszewski J; Kieslich M; Wessendorf P; Krenzlin H; Borgmann K; Nussenzweig A; Sperling K; Digweed M Mol Ther; 2016 Feb; 24(1):117-24. PubMed ID: 26265251 [TBL] [Abstract][Full Text] [Related]
33. Differential DNA damage signaling accounts for distinct neural apoptotic responses in ATLD and NBS. Shull ER; Lee Y; Nakane H; Stracker TH; Zhao J; Russell HR; Petrini JH; McKinnon PJ Genes Dev; 2009 Jan; 23(2):171-80. PubMed ID: 19171781 [TBL] [Abstract][Full Text] [Related]
34. The R215W mutation in NBS1 impairs gamma-H2AX binding and affects DNA repair: molecular bases for the severe phenotype of 657del5/R215W Nijmegen breakage syndrome patients. di Masi A; Viganotti M; Polticelli F; Ascenzi P; Tanzarella C; Antoccia A Biochem Biophys Res Commun; 2008 May; 369(3):835-40. PubMed ID: 18328813 [TBL] [Abstract][Full Text] [Related]
35. Nijmegen breakage syndrome protein (NBN) causes resistance to methylating anticancer drugs such as temozolomide. Eich M; Roos WP; Dianov GL; Digweed M; Kaina B Mol Pharmacol; 2010 Nov; 78(5):943-51. PubMed ID: 20729302 [TBL] [Abstract][Full Text] [Related]
36. Modulation of DNA damage response and induction of apoptosis mediates synergism between doxorubicin and a new imidazopyridine derivative in breast and lung cancer cells. El-Awady RA; Semreen MH; Saber-Ayad MM; Cyprian F; Menon V; Al-Tel TH DNA Repair (Amst); 2016 Jan; 37():1-11. PubMed ID: 26590797 [TBL] [Abstract][Full Text] [Related]
37. Elevated cyclin G2 expression intersects with DNA damage checkpoint signaling and is required for a potent G2/M checkpoint arrest response to doxorubicin. Zimmermann M; Arachchige-Don AS; Donaldson MS; Dallapiazza RF; Cowan CE; Horne MC J Biol Chem; 2012 Jun; 287(27):22838-53. PubMed ID: 22589537 [TBL] [Abstract][Full Text] [Related]
38. Phosphorylated Hsp27 activates ATM-dependent p53 signaling and mediates the resistance of MCF-7 cells to doxorubicin-induced apoptosis. Xu Y; Diao Y; Qi S; Pan X; Wang Q; Xin Y; Cao X; Ruan J; Zhao Z; Luo L; Liu C; Yin Z Cell Signal; 2013 May; 25(5):1176-85. PubMed ID: 23357534 [TBL] [Abstract][Full Text] [Related]
39. A murine model of Nijmegen breakage syndrome. Williams BR; Mirzoeva OK; Morgan WF; Lin J; Dunnick W; Petrini JH Curr Biol; 2002 Apr; 12(8):648-53. PubMed ID: 11967151 [TBL] [Abstract][Full Text] [Related]